Fortrea Holdings (FTRE) Other financing activities (2022 - 2023)
Fortrea Holdings' (FTRE) quarterly Other financing activities came in at -$159.9 million in Q2 2023, down 752.65% quarter-over-quarter from $24.5 million in Q1 2023.
Powered by 
Analysis
Fortrea Holdings (FTRE) Other financing activities (2022 - 2023) Analysis & Trends
Fortrea Holdings (FTRE) has reported Other financing activities for 2 consecutive years, with -$159.9 million the latest figure, recorded in Q2 2023.
- For the quarter ending Q2 2023, Other financing activities changed N/A year-over-year to -$159.9 million; the trailing twelve-month figure through Mar 2024 stood at -$159.9 million (changed N/A YoY), and the FY2023 full-year result was -$135.4 million, down 2049.21% from the prior year.
- Other financing activities eased to -$159.9 million in Q2 2023 per FTRE's latest filing, from $24.5 million in the prior quarter.
- Across five years, Other financing activities topped out at $24.5 million in Q1 2023 and bottomed at -$159.9 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -159.90 Mn |
| Mar 31, 2023 | 24.50 Mn |
| Dec 31, 2022 | -5.90 Mn |
| Sep 30, 2022 | -46.50 Mn |